Advertisement
Surgery
Subscribe to Surgery
View Sample

FREE Email Newsletter

Misonix Announces Update of Product Registration in Brazil

August 5, 2011 5:41 am | by Bio-Medicine.Org | News | Comments

FARMINGDALE, N.Y., Aug. 5, 2011 /- Misonix, Inc. (NASDAQ: MSON ), a medical device company that designs, manufactures and markets innovative therapeutic ultrasonic products worldwide for wound debridement, spinal surgery, cosmetic surgery, neurosurgery, laparoscopic surgery, and other...

Precision Optics lands $2.5M in patent sale

August 4, 2011 7:37 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Precision Optics Corp. Inc., a maker of advanced optical instruments in Gardner, has formed a deal with Intuitive Surgical Operations Inc., a surgical robotics firm in California, bringing $2.5 million to Precision Optics.

Hanger Orthopedic Group Announces Five Acquisitions Producing $20.2 million of Annual Net Revenue

August 3, 2011 6:42 am | by Bio-Medicine.Org | News | Comments

AUSTIN, Texas, Aug. 3, 2011 /- Hanger Orthopedic Group, Inc. (NYSE: HGR ) is pleased to announce the acquisition of Team Post-Op, Inc., BioConcepts, Inc., US Orthotics & Prosthetics, Inc., MK Prosthetic & Orthotic Services, Inc, and Rainier Surgical Incorporated &...

Advertisement

Misonix Announces New Distribution Agreement for Taiwan

August 3, 2011 6:42 am | by Bio-Medicine.Org | News | Comments

FARMINGDALE, N.Y., Aug. 3, 2011 /- Misonix, Inc. (NASDAQ: MSON ), a medical device company that designs, manufactures and markets innovative therapeutic ultrasonic products worldwide for wound debridement, spinal surgery, cosmetic surgery, neurosurgery, laparoscopic surgery, and other...

Cantel Medical Acquires Byrne Medical, Inc., Substantially Increasing Its Presence in GI Endoscopy

August 2, 2011 6:48 am | by Bio-Medicine.Org | News | Comments

LITTLE FALLS, N.J., Aug. 2, 2011 /- CANTEL MEDICAL CORP. (NYSE: CMN ), through its Minntech subsidiary, has acquired the business and substantially all of the assets of Byrne Medical, Inc.  Byrne Medical, privately-owned and based outside Houston, TX, designs, manufactures and sells...

MedSolutions Introduces Spine Surgery Management Program

July 21, 2011 9:48 am | by Bio-Medicine.Org | News | Comments

FRANKLIN, Tenn., July 21, 2011 /- MedSolutions , a leading provider of medical management services, today announced the launch of its Lumbar Spine Surgery Management Program for ensuring the clinical appropriateness of spine surgery for individuals suffering from lower back pain, spinal...

Dr. Andreas Kuthe Performs First Laparoscopic Procedures Using Cardica's Microcutter XPRESSâ„¢ 30 Surgical Cutting and Stapling Device

July 19, 2011 10:39 am | by Bio-Medicine.Org | News | Comments

REDWOOD CITY, Calif., July 19, 2011 /- Cardica, Inc. (Nasdaq: CRDC ) today announced that Andreas Kuthe, M.D., Chief of General Surgery at the Red Cross Hospital Clementinenhaus, Hannover, Germany, successfully completed a total of five laparoscopic procedures using Cardica's' proprietary...

Kuros Announces Allowance of US Patent for the Local Application of Parathyroid Hormone (PTH) for Bone Healing

July 19, 2011 1:42 am | by Bio-Medicine.Org | News | Comments

ZURICH, July 19, 2011 /-   Kuros Biosurgery AG, a biotechnology company focused on the development of novel biomaterials and bioactive-biomaterial combination products for trauma, wound and spinal indications, announced today that it has received Notice of Allowance for U.S....

Advertisement

Lialda® (Mesalamine) Now Approved in U.S. for Maintenance of Remission of Ulcerative Colitis

July 18, 2011 4:43 am | by Bio-Medicine.Org | News | Comments

PHILADELPHIA, July 18, 2011 /- Shire plc (LSE: SHP; NASDAQ: SHPGY ), the global specialty biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) approved Lialda® (mesalamine) Delayed Release Tablets for the maintenance of remission in patients...

Shire plc: Lialda® (Mesalamine) Now Approved in U.S. for Maintenance of Remission of Ulcerative Colitis

July 18, 2011 4:43 am | by Bio-Medicine.Org | News | Comments

PHILADELPHIA, July 18, 2011 /-   Shire plc (LSE: SHP, NASDAQ: SHPGY ), the global specialty biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) approved Lialda ® (mesalamine) Delayed Release Tablets for the maintenance of remission in...

Hologic to Participate in Four Investor Conferences

July 14, 2011 7:34 am | by Bio-Medicine.Org | News | Comments

BEDFORD, Mass., July 14, 2011 /- Hologic, Inc. (NASDAQ: HOLX ) today announced that company management will participate in the following conferences: Deborah Gordon, Vice President, Investor Relations, will host investor meetings at the Lazard Capital Markets Corporate Access Day in...

FDA: Surgical Placement of Mesh to Repair Pelvic Organ Prolapse Poses Risks

July 13, 2011 10:36 am | by Bio-Medicine.Org | News | Comments

SILVER SPRING, Md., July 13, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today issued an updated safety communication warning health care providers and patients that surgical placement of mesh through the vagina to repair pelvic organ prolapse may expose patients...

Stryker Ends Distribution Agreement With Corin PLC

July 13, 2011 7:37 am | by Bio-Medicine.Org | News | Comments

MAHWAH, N.J., July 13, 2011 /- Stryker Corporation's Orthopaedics division has reached a mutual agreement with Corin PLC in which Corin will resume direct distribution of the Cormet Hip Resurfacing System. Stryker will no longer act as a distributor of the product. "Distribution of a hip...

Advertisement

MarketsandMarkets: Lung Cancer Surgery Market (Devices & Treatment Outlook) to be US$ 46.5 Billion by 2015

June 30, 2011 8:36 am | by Bio-Medicine.Org | News | Comments

DALLAS, Texas, June 30, 2011 /- The ' Lung Cancer Surgery Market (Devices & Treatment Outlook) - Trends & Challenges (2010 - 2015) " analyzes the lung cancer market by types of surgical procedures and surgical devices and studies the market dynamics of North America, Europe and...

Boston Scientific Welcomes Publication of Landmark Report on Chronic Pain

June 30, 2011 8:36 am | by Boston Scientific | News | Comments

NATICK, Mass., June 30, 2011 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) welcomes the recent landmark report to Congress by the Institute of Medicine (IOM) of the National Academy of Sciences titled Relieving

Ovarian Cancer Genome Mapped, Opens Door to Personalized Medicine

June 29, 2011 9:36 am | by Lawrence Berkeley National Laboratory | News | Comments

Scientists have developed the first comprehensive catalog of the genetic aberrations responsible for an aggressive type of ovarian cancer that accounts for 70 percent of all ovarian cancer deaths. Hundreds of researchers from more than 80 institutions, including scientists from Berkeley...

Ascension Orthopedics Implants PyroTITANâ„¢ in Geelong, Australia

June 29, 2011 9:36 am | by Bio-Medicine.Org | News | Comments

AUSTIN, Texas, June 29, 2011 /- Ascension Orthopedics, Inc., the world leader in PyroCarbon orthopedic implants, announces the implantation of the PyroTITAN™ Humeral Resurfacing Implant in Geelong, Australia by Richard S. Page, MB.BS.FRACS(ORTH) at St. John of God Hospital. "The...

Pacira Pharmaceuticals, Inc. Announces Inclusion in Russell 3000 Index

June 27, 2011 3:35 am | by Bio-Medicine.Org | News | Comments

PARSIPPANY, N.J., June 27, 2011 /- Pacira Pharmaceuticals, Inc ., (Nasdaq: PCRX ), an emerging specialty pharmaceutical company, today announced that it has been included in the Russell 3000® Index following Russell Investments' reconstitution of its comprehensive set of U.S. and...

New Study Finds That Gastric Banding Pays for Itself In Approximately Two Years for Patients With Diabetes and Four Years for Patients Without Diabetes

June 22, 2011 6:45 am | by Bio-Medicine.Org | News | Comments

IRVINE, Calif., June 22, 2011 /- Allergan, Inc. (NYSE: AGN ) today announced a new study published in the peer-reviewed journal Surgery for Obesity and Related Diseases that found the cost of a gastric banding weight-loss surgery procedure, such as Allergan's LAP-BAND® Adjustable...

ProStrakan Receives FDA Approval for Rectivâ„¢ for the Treatment of Moderate to Severe Pain Associated With Chronic Anal Fissures

June 22, 2011 5:33 am | by Bio-Medicine.Org | News | Comments

GALASHIELS, Scotland, and BEDMINSTER, N.J., June 22, 2011 /- ProStrakan Group plc, a subsidiary of Kyowa Hakko Kirin Co. Ltd., and an international specialty pharmaceutical company, today announces that it has received approval from the U.S. Food and Drug Administration (FDA) for...

MedShape Solutions, Inc. Announces Extension of ExoShapeâ„¢ Product Line in Response to Surgeon Demand

June 20, 2011 9:43 am | by Bio-Medicine.Org | News | Comments

ATLANTA, June 20, 2011 /- MedShape Solutions, Inc., the industry leader in innovative shape memory orthopedic devices, today announced it has developed new, larger sizes of its ExoShape CL, a two-part PEEK Altera™ interference fixation device that simplifies and improves soft tissue...

BioMedixâ„¢ Announces John Martin, MD, FACS, as Medical Director

June 16, 2011 11:36 am | by Bio-Medicine.Org | News | Comments

SAINT PAUL, Minn., June 16, 2011 /- BioMedix™, a health IT company focused on improving lives through integrated medical devices and software, announces the appointment of John Martin, MD, FACS, as Medical Director. A respected researcher and author, Dr. Martin is one of the only...

Largest Acellular Dermal Allografts Available for Abdominal Wall Reconstruction Introduced at AWR 2011

June 16, 2011 11:36 am | by Bio-Medicine.Org | News | Comments

WASHINGTON, June 16, 2011 /- The largest human dermal allograft available on the market today for hernia and abdominal wall repair will be introduced at the AWR meeting here this week.  The Musculoskeletal Transplant Foundation (MTF), the nation's leading tissue bank, is introducing...

Reportlinker Adds US Wound Closure Devices - Market Trend Till 2016

June 16, 2011 6:33 am | by Bio-Medicine.Org | News | Comments

NEW YORK, June 16, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: US Wound Closure Devices – Market Trend Till 2016...

Covidien Announces Organizational Changes(2)

June 15, 2011 5:34 pm | by Covidien | News | Comments

DUBLIN, Jun 15, 2011 (BUSINESS WIRE) --Covidien (NYSE: COV), a leading global provider of healthcare products, today announced several leadership changes that will streamline its organization to accelerate growth and innovation. These changes are all effective July 1, 2011. Bryan C....

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading